Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy

Natalizumab, a highly effective therapy for relapsing-remitting multiple sclerosis, is associated with a risk of progressive multifocal leukoencephalopathy (PML). The objective of this analysis was to examine factors predicting survival in a large natalizumab-associated PML global population. Patien...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Neurovirol
Glavni autori: Dong-Si, Tuan, Gheuens, Sarah, Gangadharan, Amy, Wenten, Made, Philip, Jeffrey, McIninch, James, Datta, Shoibal, Richert, Nancy, Bozic, Carmen, Bloomgren, Gary, Richman, Sandra, Weber, Thomas, Clifford, David B.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4628054/
https://ncbi.nlm.nih.gov/pubmed/25771865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13365-015-0316-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items